The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab.
 
Udit Nindra
No Relationships to Disclose
 
Samuel Xavier Stevens
No Relationships to Disclose
 
Adel Shahnam
No Relationships to Disclose
 
Abhijit Pal
No Relationships to Disclose
 
Tamiem Adam
No Relationships to Disclose
 
Po Yee Yip
No Relationships to Disclose
 
Jenny HJ Lee
Honoraria - BMSi; MSD; Sanofi
Consulting or Advisory Role - Sanofi
Research Funding - MSD
Travel, Accommodations, Expenses - BMSi; Novartis
 
Michael J. Boyer
Honoraria - AstraZeneca; CancerAid
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst)
Research Funding - Amgen (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Imugene (Inst); Janssen (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst)
 
Adnan Nagrial
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Research Funding - Akeso Biopharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Steven Chuan-Hao Kao
Honoraria - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Victoria Jane Bray
No Relationships to Disclose